The University of California's 2026 grant funds early-stage investigators in California for innovative basic and translational HIV research projects addressing critical scientific gaps.
Funder: University of California
Due Dates (Anticipated): May 2027: Letters of Intent (LOI) Due (projected) | July 2027: Full Applications Due (projected)
Funding Amounts: Up to $200,000 direct costs over 2 years (plus capped indirects); supplemental $10,000 available after year one for student/trainee support.
Summary: Supports innovative, high-risk basic biomedical and translational HIV research by early-stage investigators in California where federal funding has declined.
Key Information: Only early-stage investigators at California non-profits are eligible; requires a mentor and a robust mentoring plan.
This program from the California HIV/AIDS Research Program (CHRP), administered by the University of California, funds pilot studies in basic and translational biomedical HIV science led by early-stage investigators (ESIs) at California non-profit institutions. The initiative is designed to sustain and advance critical HIV research areas that are increasingly neglected by federal agencies, with a special focus on prevention, care for priority communities, and supporting the next generation of investigators. Projects should address emerging or understudied questions in HIV biology, mechanisms, or translation to interventions, and are intended to generate preliminary data for future larger grants.